Skip to main content
Yifeng Pharmacy Chain Co., Ltd. logo

Yifeng Pharmacy Chain Co., Ltd. — Investor Relations & Filings

Ticker · 603939 ISIN · CNE100001TS5 LEI · 300300CZZIF44N1EZO06 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,865 across all filing types
Latest filing 2023-05-15 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 603939

About Yifeng Pharmacy Chain Co., Ltd.

https://www.yfdyf.cn/

Yifeng Pharmacy Chain Co., Ltd. operates as a large-scale retail pharmacy enterprise. The company specializes in the distribution and sale of prescription drugs, over-the-counter medicines, traditional Chinese medicine, nutritional supplements, and medical devices. It utilizes a standardized management system across its extensive network of retail stores to ensure service quality and operational efficiency. Beyond physical retail, the company has developed a comprehensive digital healthcare ecosystem, integrating online-to-offline (O2O) services to provide professional pharmaceutical consultations and health management solutions. Its business model focuses on a "big health" strategy, aiming to provide accessible healthcare products and professional services to a broad consumer base through optimized supply chain logistics and a diversified product portfolio.

Recent filings

Filing Released Lang Actions
关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券申请文件的审核问询函的回复报告（2022年报更新稿）
Capital/Financing Update Classification · 95% confidence The document is a detailed reply report to an inquiry letter from the Shanghai Stock Exchange regarding the application for issuance of convertible corporate bonds by Yifeng Pharmacy Chain Co., Ltd. It contains extensive operational, contractual, and regulatory compliance information about the company's online business models, revenue breakdowns, and required licenses. The document is lengthy (15,000 characters) and is a formal response to a regulatory inquiry related to a financing activity (issuance of convertible bonds). It is not a financial report like an annual or interim report, nor is it a transcript, audit report, or management change announcement. The content focuses on the company's capital raising process and regulatory compliance for the bond issuance. Therefore, the document best fits the category of Capital/Financing Update (CAP).
2023-05-15 Chinese
益丰药房关于收到上海证券交易所《关于益丰大药房连锁股份有限公司向不特定对象发行可转换公司债券的审核中心意见落实函》的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the company regarding receipt of a regulatory communication from the Shanghai Stock Exchange about the company's application to issue convertible bonds to unspecified investors. It discusses the review process, the need to address issues raised, and the requirement for further approvals before implementation. The document is short (780 characters) and primarily serves as a regulatory update on financing activities, not the actual financing report or detailed financial data. Therefore, it fits best under Capital/Financing Update (CAP).
2023-05-15 Chinese
益丰药房2022年年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as the "2022 年年度股东大会" (2022 Annual General Meeting) of 益丰大药房连锁股份有限公司. It contains detailed meeting agenda, meeting rules, multiple proposals to be voted on, reports from the board of directors and supervisory board, voting procedures, and legal opinions related to the AGM. The content is consistent with materials typically shared during an Annual General Meeting, including reports and resolutions to be approved by shareholders. The document length is substantial (15,000 characters), and it is not merely an announcement of a report but the actual meeting materials. Therefore, this document fits the category of AGM Information (AGM-R).
2023-05-10 Chinese
独立董事关于公司第四届董事会第二十五次会议相关事项的独立意见
Audit Report / Information Classification · 90% confidence The document is an independent opinion from the independent directors regarding a verification report on the company's weighted average return on net assets and non-recurring gains and losses over the past three years. It references an audit report issued by an accounting firm but does not contain the full audit report itself. The document is short (601 characters) and serves as an opinion or certification related to the audit report rather than the report itself. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit findings and independent opinions on them, rather than being a full annual report or a regulatory filing. Confidence is high due to clear references to audit verification and independent director opinion. FY 2022
2023-05-08 Chinese
益丰药房关于2022年年度股东大会增加临时提案的公告
AGM Information Classification · 95% confidence The document is an announcement regarding the addition of a temporary proposal to the 2022 Annual General Meeting (AGM) of Yifeng Pharmacy Chain Co., Ltd. It details the date of the AGM, the proposal submitted by a shareholder, and the agenda items to be voted on at the meeting. The document includes procedural information about the meeting, voting methods, and proxy authorization forms. It does not contain the actual annual report, financial statements, or detailed financial data but rather focuses on the meeting logistics and agenda. Therefore, this document is best classified as AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM agenda.
2023-05-08 Chinese
益丰药房第四届监事会第二十二次会议决议公告
Audit Report / Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Yifeng Pharmacy Chain Co., Ltd. It details the convening and voting results of the 22nd meeting of the 4th Supervisory Board. The key content includes approval of a verification report on the company's weighted average return on net assets and non-recurring gains and losses over the past three years, issued by an accounting firm. The document is short (841 characters) and primarily announces the meeting resolution and the approval of an audit-related report, but does not contain the full audit report itself or detailed financial statements. It is not an Annual Report (10-K), Interim Report (IR), or Earnings Release (ER). It is not a Board/Management change announcement (MANG) or a voting result declaration (DVA) since it relates to Supervisory Board meeting resolutions rather than shareholder votes. The document fits best as an Audit Report / Information (AR) because it references and approves an audit verification report by an accounting firm, which aligns with the definition of standalone audit reports and applied accounting principles. Confidence is high given the clear mention of the audit verification report and the nature of the meeting resolution. FY 2023
2023-05-08 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.